Results 151 to 160 of about 16,312 (208)
Comparison of the effects of non-calcium and calcium-based phosphate binders on fibroblast growth factor-23 levels in patients with CKD-mineral and bone disorder: a meta-analysis of randomized controlled trials. [PDF]
BMC NephrolCha S, Baek M, Jung C, Kim H.
europepmc +1 more source
Fatal Hyperphosphatemia After a Single Phosphate Enema in Ogilvie Syndrome. [PDF]
CureusMonteiro I +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Emerging drugs for hyperphosphatemia
Expert Opinion on Emerging Drugs, 2007Cardiovascular mortality is the leading cause of death in the uremic patient. Hyperphosphatemia is considered an independent risk factor associated with cardiovascular morbidity and mortality in dialysis patients. As phosphate control is not efficient with diet or dialysis, phosphate binders are commonly prescribed in patients with chronic renal ...
Santoro Domenico +2 more
exaly +3 more sources
Review of the Literature: Severe Hyperphosphatemia
The American Journal of the Medical Sciences, 1995 A patient with a markedly elevated serum phosphorus level (23.9 mg/dL) is described, followed by a brief review of severe hyperphosphatemia. Elevated serum phosphorus levels may be artifactual or true. True hyperphosphatemia is usefully subdivided according to (a) whether phosphorus is added to the extracellular fluid from a variety of exogenous or ...
L, Thatte +5 more
openaire +3 more sources
Prevention and treatment of hyperphosphatemia in chronic kidney disease
Kidney International, 2018 Hyperphosphatemia has consistently been shown to be associated with dismal outcome in a wide variety of populations, particularly in chronic kidney disease (CKD). Compelling evidence from basic and animal studies elucidated a range of mechanisms by which
Adriana van Ballegooijen +1 more
exaly +2 more sources